Published On: Wed, Feb 3rd, 2021
World | By

GlaxoSmithKline, CureVac to make COVID-19 vaccines aimed at new variants

Virus Outbreak Germany Vaccine

Drugmaker GlaxoSmithKline says it will work with German biopharmaceutical company CureVac to develop new vaccines targeting emerging variants of coronavirus. The announcement comes amid concerns that some mutations are making the virus harder to combat COVID-19.

CBC | World News